Evasion of Type I Interferon by SARS-CoV-2

Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo, Shi, Pei-Yong·2020·Cell Reports
DOI 10.1016/j.celrep.2020.108234

Cited by (956)

Items 801–900 of 956

  1. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  2. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  3. Antiviral immune responses, cellular metabolism and adhesion are differentially modulated by SARS-CoV-2 ORF7a or ORF7b
    Tránsito García‐García, Raúl Fernández‐Rodríguez, Natalia Redondo, Ana de Lucas‐Rius, Sara Zaldívar‐López, Blanca Dies López-Ayllón, José M. Suárez-Cárdenas, Ángeles Jiménez-Marín, María Montoya, Juan J. Garrido · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  4. Discovering host protein interactions specific for SARS-CoV-2 RNA genome
    Roberto Giambruno, Elsa Zacco, Camilla Ugolini, Andrea Vandelli, Logan Mulroney, Manfredi D’Onghia, Bianca Giuliani, Elena Criscuolo, Matteo Castelli, Nicola Clementi et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Low-Dose Interferon I and Iii-Based Nasal Sprays: A Good-Looking Covid-19 Vaccine Candidate?
    Theodor-Nicolae Carp, Michael Metoudi · 2022 · Preprints.org
  6. Low-Dose Interferon I and III-Based Nasal Sprays: A Good-Looking COVID-19 Vaccine Candidate?
    Theodor-Nicolae Carp, Michael Metoudi, Brent Brown, Vanshika Ojha · 2023 · Preprints.org
  7. Pathways to altered virulence of SARS-CoV-2
    Laura Forsberg White, Debra Van Egeren, Madison Stoddard, Nico D'Angelo, Henry Bayly, Manish Sagar, Arijit Chakravarty · 2023 · OSF Preprints (OSF Preprints)
  8. Implications of SARS‐CoV‐2 Immunity in the Context of the Pathogenesis of COVID‐19, Immune Evasion of the Virus, and the Effectiveness of Vaccination
    Hikmet Akkız · 2024 · Preprints.org
  9. Inflammation cellular platform (INCEPLAT) for testing anti-inflammatory compounds for SARS-CoV-2
    Blanca D. López‐Ayllón, Laura Mendoza‐García, Ana de Lucas‐Rius, Tránsito García‐García, Raúl Fernández‐Rodríguez, Antonio Romero-Guillen, Judit Serrat, Sonia Zúñiga, Natalia Redondo, Mar Siles‐Lucas et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  10. SARS-CoV-2 nucleocapsid uniquely disrupts chromatin over pathophysiologically relevant gene promoters
    Jane M Benoit, Jonathan H. Dennis · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Deletion of a KSF Motif Attenuates NSP1 Host Cell Translation Shutoff and Impairs SARS-CoV-2 Virulence
    Chengjin Ye, Shahrzad Ezzatpour, Brian Imbiakha, Nathaniel D. Jackson, Tolga Çağatay, Anastasija Čupić, Lisa Miorin, Annette Choi, David W. Buchholz, Jordan Carter et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  12. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  13. Immune Responses to SARS CoV-2: A Scoping Review
    Michael Nyongesa Walekhwa, Richard Kagia, Margaret Muturi · 2021 · European Journal of Medical and Health Sciences
  14. SARS-CoV-2の病態生理
    史雄 中村, 綾子 石津 · 2021 · Institutional Repositories DataBase (IRDB)
  15. Comparing Expression of OAS-RNaseL Pathway-Related Genes in SARS-CoV-2 and Similar Viruses
    Nikhil Chakravarty, Penelope A. Edillor, Andy P. Huang, Giovanni A. Torres, Manal T. Usmani, Pavan Kadandale · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  16. The Experts Speak: A New Feature in the JICR
    Michael Gale, Ram Savan, Adolfo García‐Sastre, Ludmila Prokunina‐Olsson, Kuppusamy Balamurugan, Howard A. Young · 2021 · Journal of Interferon & Cytokine Research
  17. Engineered chimeric T cell receptor fusion construct (TRuC)-expressing T cells prevent translational shutdown in SARS-CoV-2-infected cells
    Ira Godbole, Kevin Ciminski, Omid Sascha Yousefi, Salma Pathan-Chhatbar, Deniz Saltukoglu, Niklas Vesper, Pavel Salavei, Juliane Strietz, Nicole Gensch, Michael G. Reth et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Secondary Publication: The Pathophysiology of COVID-19 (Coronavirus Disease 2019) Caused by the Infection of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)
    Ayako Nakamura‐Ishizu, Fumio Nakamura · 2021 · Institutional Repositories DataBase (IRDB)
  19. Tissue-specific ramp sequences correspond with increased gene expression in humans and SARS-CoV-2
    Justin B. Miller, Taylor E Meurs, Matthew W. Hodgman, Benjamin P. Song, Mark Ebbert, John S. K. Kauwe, Perry G. Ridge · 2021 · Research Square
  20. Woodsmoke particulates alter expression of antiviral host response genes in human nasal epithelial cells infected with SARS-CoV-2 in a sex-dependent manner
    Stephanie A. Brocke, Grant T. Billings, Sharon Taft-Benz, Neil E. Alexis, Mark T. Heise, Ilona Jaspers · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  21. Overview of the immune response against SARS-CoV-2
    Leticia Cedillo‐Barrón, Julio García‐Cordero, Noe Juvenal Mendoza‐Ramírez, Sandra Paola Martínez-Frías · 2021 · Elsevier eBooks
  22. Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?
    Shoumen Datta · 2021
  23. Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
    Chaja Katzman, Tomer Israely, Sharon Melamed, Boaz Politi, Assa Sittner, Yfat Yahalom-Ronen, Shay Weiss, Reem Abu Rass, Rachel Zamostiano, Eran Bacharach et al. · 2021 · Viruses
  24. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  25. Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?
    Shoumen Datta · 2021
  26. Pegylated-interferon-λ treatment-induced peripheral interferon stimulated genes are associated with SARS-CoV-2 viral load decline despite delayed T cell response in older individuals
    Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, D. Lorne Tyrrell, Jordan J. Feld, Adam J. Gehring · 2022 · medRxiv
  27. Superiorly Broad Natural Immunity to Covid Infection Can Potentially Provide Longer Lasting Protection against Immune Evasion by Emerging Variants from Alpha to Omicron and Possibly Beyond to Omega
    Girish Jayant Kotwal · 2022 · Journal of Virology Research & Reports
  28. A systematic review of the variants of Sars-Cov-2
    Mohammed Farhan Qureshi, Shoeb Qureshi · 2022 · International Journal of Science and Research Archive
  29. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  30. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  31. Aptamers for Detection and Diagnostics (ADD): Can mobile systems linked to biosensors support molecular diagnostics of SARS-CoV-2? Should molecular medicine explore multiple alternatives as adjuvants to or replacement for traditional and non-traditional vaccines?
    Shoumen Datta · 2021
  32. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  33. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  34. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  35. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  36. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  37. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  38. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  39. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  40. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  41. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  42. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  43. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  44. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  45. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  46. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  47. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  48. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  49. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  50. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  51. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  52. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  53. Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?
    Shoumen Datta · 2021
  54. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  55. Coronaviruses
    Jennifer Louten · 2022 · Elsevier eBooks
  56. SARS-CoV-2 type I Interferon modulation by nonstructural proteins 1 and 2
    Émile Lacasse, Isabelle Dubuc, Leslie Gudimard, Annie Gravel, Isabelle Allaeys, Éric Boilard, Louis Flamand · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Origin, evolution, and pathogenesis of coronaviruses
    Sanjay Rathod · 2022 · Elsevier eBooks
  58. Research Progress of SARS-CoV-2 Omicron Variant
    Kang-Hong Wang · 2022 · Advances in microbiology
  59. The Evolution of SARS-CoV-2
    Susan F. Bailey, Mahfuza Akter · 2022 · Springer eBooks
  60. Genomic, proteomic and metabolomic profiling of severe acute respiratory syndrome-Coronavirus-2
    Bijina J. Mathew, Sudheer Gupta, Ram Kumar Nema, Ashish Kumar Vyas, Prashant S. Khare, Debasis Biswas, Anirudh K. Singh · 2022 · Elsevier eBooks
  61. The innate immune response to SARS-CoV-2
    Ken Takashima, Hiroyuki Oshiumi · 2021 · Uirusu
  62. Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
    Baxolele Mhlekude, Dylan Postmus, January Mikolaj Weiner, Saskia Stenzel, Francisco José Zapatero Belinchón, Ruth Olmer, Jenny Jansen, Anja M. Richter, Julian Heinze, Nicolas Heinemann et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  63. Macrophage Boolean networks in the time of SARS-CoV-2
    Ugo Avila-Ponce de León, Osbaldo Reséndis-Antonio · 2022 · Frontiers in Immunology
  64. Pandemics and the English Language: Concepts Critical for Conversing About COVID-19
    Neil S. Greenspan, Guillermo A. Pereda · 2022 · Pathogens and Immunity
  65. Immunosenescence and ACE2 protein expression: Association with SARS-CoV-2 in older adults
    Altamirano Gustavo Acosta, Rodríguez Carlos E Miguel, Reyes-Montes María del Rocío, Esperanza Duarte-Escalante, Acosta-Reyes Rocío, Carlos U. Torres-Estrella, Valencia-Ledezma Omar E · 2022 · Open Journal of Asthma
  66. II. COVID-19: How Far Has the Pathogenesis been Elucidated?
    Norio Ohmagari · 2021 · Nihon Naika Gakkai Zasshi
  67. MANIFESTAÇÕES CLÍNICAS PREVALENTES NA SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA PÓS COVID-19: UMA REVISÃO DE LITERATURA
    Tamara Ribeiro de Oliveira, Carolina Da Lozzo Mello, Ana Rhara Bergemann Souza Oliva Lima, Bruna Maria Rodrigues Yochida · 2022 · Editora Conhecimento Livre eBooks
  68. ASSISTÊNCIA A PESSOAS PORTADORAS DE LESÃO POR PRESSÃO
    Amanda Borba Barbosa, Lorena Daher Carneiro Oliva, Janaina Nascimento Lassala, Patricia Bispo da Silva, Georgia Neves da Silva, Roseli Oliveira Almeida, Ana Paula Fernandes de Carvalho, Andréia de Jesus Soares, Rosangela Ribeiro de Souza, Ana Carla Barbosa de Oliveira · 2022 · Editora Conhecimento Livre eBooks
  69. Relato de Caso Leishmaniose Tegumentar Americana ocorrido no município de Itaperuna, RJ, com revisão de literatura
    Bruna Fontes Passalini Gonçalves, João Marcos Moreira de Oliveira, Alexandre Harfouche Filipo Fernandes · 2022 · Editora Conhecimento Livre eBooks
  70. Doença articular degenerativa, artrose ou osteoartrose: relato de caso
    João Victor Pinto de Arruda Guimarães, Lucas da Cruz Farias, Amanda Tadiane Mocelin, Daniel Mocelin Neto, Luana Clementino Martiniano · 2022 · Editora Conhecimento Livre eBooks
  71. Repercussões do uso abusivo de anabolizantes na função sexual masculina.
    Alexandre Eustáquio de Almeida Rezende Filho, Victória Carneiro Maciel, Lucca Piacesi Muniz de Melo, Matheus Serwy Fiuza de Moraes, Gabriel Gomes Knust de Sousa, João Victor da Costa, João Victor de Assis Crispim, Vinícius Duarte Silva, Ana Luiza Café Lopes, Maria Vitória Graça Couto de Campos Amaral · 2022 · Editora Conhecimento Livre eBooks
  72. USO INADEQUADO DE TERAPIA HORMONAL POR MULHERES NO CLIMATÉRIO
    Nathalia Alfaix Martins Palheiro Vicente, FELIPE RODRIGUES BRAZ, LAURO BARBOSA NETO, NILTON SANTOS QUIRINO, TIAGO CANDIDO DE SÁ · 2022 · Editora Conhecimento Livre eBooks
  73. Desafios encontrados na minimização dos erros de medicação em ambientes hospitalares
    Mirelly Santos França, Gabriel de Oliveira Medeiros, Evelin Isabele Rosa Mendes · 2022 · Editora Conhecimento Livre eBooks
  74. PANORAMA CIENTÍFICO DA CATARATA CONGÊNITA: UMA REVISÃO DE LITERATURA
    Beatriz Nunes Ferraz de Abreu Zech Sylvestre, Tatiana Pinheiro Dantas, João Crispim Moraes Lima Ribeiro, Juliana de Lucena Martins Ferreira · 2022 · Editora Conhecimento Livre eBooks
  75. PRINCIPAIS FATORES ENVOLVIDOS NA INCIDÊNCIA DO TRANSTORNO DO ESPECTRO AUTISTA: UMA REVISÃO DE LITERATURA INTEGRATIVA
    Dhyeillen Ayllen Weber, Camila Vasquez Barros, Maria Fernanda Boehm Piovezan, Mariana Santana dos Santos Giolo, Paula Helena de Almeida Gattass Bumlai · 2022 · Editora Conhecimento Livre eBooks
  76. PERFIL DA RESPOSTA IMUNOLÓGICA NA COVID-19
    Renata Dellalibera-Joviliano, Carlos Eduardo Kakunaka, Yuri Felix Pedra, Edileine Dellalibera · 2022 · Editora Conhecimento Livre eBooks
  77. EXISTE INFLUÊNCIA DA TORÇÃO TESTICULAR UNILATERAL NA FERTILIDADE MASCULINA? - UMA REVISÃO DA LITERATURA
    Natalia Velasco de Azevedo, Marina Grzybowski Paranhos · 2022 · Editora Conhecimento Livre eBooks
  78. A PARTICIPAÇÃO DO MECANISMO INFLAMATÓRIO DO ÓXIDO NÍTRICO NAS LESÕES DO TECIDO CARDÍACO
    Bruno Lepera Estabile, Victor Antonio Costa Faria, Renata Dellalibera-Joviliano · 2022 · Editora Conhecimento Livre eBooks
  79. The Rationale Behind the Effectiveness of COVID-19 Vaccines and Associated Immunological Mechanisms
    Sami El Khatib · 2022 · Turkish Journal of Immunology
  80. Innate immune responses in COVID-19
    Etienne D. Jacotot, Laura Talamini, Srinivasa Reddy Bonam, Angelica Thomas Vieira, Véronique Frémeaux‐Bacchi, Marko Z. Radic, Marie‐Agnès Dragon‐Durey, José Manuel Lozano, Rafael Simone Saia, Sylviane Muller · 2023 · Elsevier eBooks
  81. Análise de células Natural Killer de memória e da resposta antiviral de células T CD8+ na infecção por SARS-CoV-2
    Sarah Cristina Gozzi-Silva · 2022
  82. Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
    L. A. Oleinik, Павел Геннадьевич Мадонов, М. Б. Пыхтина · 2023 · Molecular Biology
  83. SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
    Aarthi Goverdhan · 2023 · Elsevier eBooks
  84. Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond
    Giuseppe Lippi, Brandon Michael Henry · 2023 · European Journal of Internal Medicine
  85. Mucus hypersecretion in COVID-19 patients: signaling pathway and related targeted therapies
    SiYi TAO, Juan YUE, X.Y. Zhong, Shanni Li, Zanxian Xia · 2023 · Scientia Sinica Vitae
  86. Recent Advances in Novel Inhibitor Molecules Development Targeting RNA Helicase (Nonstructural Protein 13) of SARS-CoV-2: Review
    Raghunath Satpathy, Sonali Acharya · 2023 · Journal Of Biochemical Technology
  87. Pandemic preparedness through genomic surveillance: Overview of mutations in SARS-CoV-2 over the course of COVID-19 outbreak
    Fares Z. Najar, Chelsea L. Murphy, Evan Linde, Veniamin A. Borin, Huan Wang, Shozeb M Haider, Pratul K. Agarwal · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  88. ORF6, a repressor of the MHC class I pathway: new molecular target for SARS-CoV-2 drug discovery?
    Baohui Zhu, Ryota Ouda, Paul de Figueiredo, Koichi S. Kobayashi · 2023 · Expert Opinion on Therapeutic Targets
  89. Efficacy of thymosin-α-1 in patients with COVID-19: A systematic review and meta-analysis
    Pu Wang, Chang-Hong Wang, Dawei Chen · 2023 · European Journal of Inflammation
  90. Interference of SARS-CoV-2 on type Ⅰ IFN-mediated antiviral response
    Lai Wei · 2023 · International Conference on Modern Medicine and Global Health (ICMMGH)
  91. Identification of potential drug targets for COVID 19 patients with cytokine storm
    Bayu Cakra Buana, Natapol Pornputtapong · 2022 · Chula Digiverse
  92. Third-Party Cytotoxic T Lymphocytes for High-Risk Patients with Covid-19
    Dolores A. Grosso, John L. Wagner, Allyson O’Connor, Kaitlyn Keck, Yanping Huang, Zixuan Wang, Hilary Mehler, Benjamin E. Leiby, Phyllis R. Flomenberg, Usama S. Gergis et al. · 2023 · Research Square
  93. Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection
    Baxolele Mhlekude, Dylan Postmus, January Weiner, Saskia Stenzel, Francisco José Zapatero Belinchón, Ruth Olmer, Jenny Jansen, Anja M. Richter, Julian Heinze, Nicolas Heinemann et al. · 2023 · PLoS Pathogens
  94. Autologous Platelet-Rich Plasma: A Potential Therapy to Mitigate Severe Covid-19 Manifestations
    Saktivi Harkitasari, I Wayan Sumardika, ‪Cokorda Agung Wahyu Purnamasidhi, I Komang Hotra Adiputra, Giovanca Verentzia Purnama, Richard Christian Suteja · 2023 · Biomedical & Pharmacology Journal
  95. Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics
    Vaishali Waman, Paul Ashford, Su Datt Lam, Neeladri Sen, Mahnaz Abbasian, Laurel Woodridge, Yonathan Goldtzvik, Nicola Bordin, Jiaxin Wu, Ian Sillitoe et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Predicting Antibody and ACE2 Affinity for SARS-CoV-2 BA.2.86 and JN.1 with In Silico Protein Modeling and Docking
    Shirish Yasa, Sayal Guirales-Medrano, Denis Jacob Machado, Colby T. Ford, Daniel A. Janies · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  97. The Covid-19 and TB Syndemic: Differences and Similarities
    Stefan H. E. Kaufmann, Alan Sher, Alex Sigal, Birgit Sawitzki · 2023 · Frontiers research topics
  98. Multiple layers of innate immune response antagonism of SARS-CoV-2
    Fuchun Zhou, Sivakumar Periasamy, Nathaniel D. Jackson, Wan Sze Cheng, Rubén Soto-Acosta, Philipp A. Ilinykh, Chengjin Ye, Shailendra Chauhan, German Nudelman, Elena Zaslavsky et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  99. COVID-19-Induced Vascular Coagulopathy
    Sabari Nath Neerukonda · 2024 · Elsevier eBooks
  100. Inmunopatogénesis de la Infección por SARS-CoV-2
    Serrano-Coll, Héctor, Rivero Herrera, Ricardo · 2023